Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 11/2022

Open Access 26.05.2022 | Correction

Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T

verfasst von: Eline A. M. Ruigrok, Giulia Tamborino, Erik de Blois, Stefan J. Roobol, Nicole Verkaik, Marijke De Saint-Hubert, Mark W. Konijnenberg, Wytske M. van Weerden, Marion de Jong, Julie Nonnekens

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2022

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
This article is part of the Topical Collection on Erratum.
The original article can be found online at https://​doi.​org/​10.​1007/​s00259-022-05821-w

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Correction to: European Journal of Nuclear Medicine and Molecular Imaging
The publisher regrets that the Tables 2 and 3 that appear in the original article are incorrect. The correct tables appear below.
Table 2
Self-absorbed dose rates to the nucleus per unit activity (Gy(Bq*s)-1) depending on radionuclide localization (i.e. cell membrane and cytoplasm) and cellular dimension (i.e. minimum, average and maximum)
Floating set-up (spherical cells)
Dimension
Source compartment
 
Cell membrane
Cytoplasm
 
Lutetium-177
Actinium-225
Lutetium-177
Actinium-225
Minimum
2.02E-04
1.05E-01
3.67E-04
1.78E-01
Average
1.04E-04
5.63E-02
1.98E-04
1.01E-01
Maximum
6.40E-05
3.56E-02
1.23E-04
6.48E-02
Attached cells set-up (ellipsoidal shape)
Dimension
Source compartment
 
Cell membrane
Cytoplasm
 
Lutetium-177
Actinium-225
Lutetium-177
Actinium-225
Minimum
3.43E-04
1.61E-01
2.14E-04
1.09E-01
Average
1.65E-04
8.31E-02
1.16E-04
6.15E-02
Maximum
7.66E-05
4.05E-02
5.89E-05
3.23E-02
Contribution of the radioactive medium
 
Lutetium-177
 
Actinium-225
 
 
2.30E-11
 
4.57E-09
 
Table 3
Absorbed dose (Gy) accumulated over 7 days (i.e. duration of clonogenic survival assay) of either [177Lu]Lu-PSMA-I&T or [225Ac]Ac-PSMA-I&T treatment. The absorbed dose is reported for 3 cellular dimension assumptions (i.e. average, minimum and maximum) in order to provide the average and maximum range of variation of the absorbed dose calculations
[177Lu]Lu-PSMA-I&T
   
  
Dimension
 
Concentration (MBq/mL)
Average
Minimum
Maximum
0
0
0
0
0.1
0.74
1.48
0.37
0.2
1.48
2.96
0.74
0.3
2.22
4.43
1.11
0.4
2.96
5.91
1.48
0.5
3.70
7.39
1.85
[225Ac]Ac-PSMA-I&T
   
  
Dimension
 
Concentration (kBq/mL)
Average
Minimum
Maximum
0
0
0
0
0.037
0.08
0.16
0.04
0.1
0.22
0.42
0.11
0.185
0.41
0.78
0.21
0.25
0.56
1.05
0.29
0.37
0.83
1.55
0.42
0.5
1.12
2.10
0.57
0.75
1.67
3.15
0.86
The original article has been corrected.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement


Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

© Springer Medizin

e.Med Radiologie

Kombi-Abonnement

Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.

© Springer Medizin

Metadaten
Titel
Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T
verfasst von
Eline A. M. Ruigrok
Giulia Tamborino
Erik de Blois
Stefan J. Roobol
Nicole Verkaik
Marijke De Saint-Hubert
Mark W. Konijnenberg
Wytske M. van Weerden
Marion de Jong
Julie Nonnekens
Publikationsdatum
26.05.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2022
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05845-2

Weitere Artikel der Ausgabe 11/2022

European Journal of Nuclear Medicine and Molecular Imaging 11/2022 Zur Ausgabe